Ascendis Pharma AS (ASND)
129.81
+7.17
(+5.85%)
USD |
NASDAQ |
Nov 22, 16:00
134.49
+4.68
(+3.61%)
After-Hours: 20:00
Ascendis Pharma Profit Margin (Quarterly): -171.5% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -171.5% |
| June 30, 2024 | -303.9% |
| March 31, 2024 | -136.6% |
| December 31, 2023 | -63.09% |
| September 30, 2023 | -337.7% |
| June 30, 2023 | -256.2% |
| March 31, 2023 | -330.2% |
| December 31, 2022 | -905.9% |
| September 30, 2022 | -1.11K% |
| June 30, 2022 | -1.32K% |
| March 31, 2022 | -1.84K% |
| December 31, 2021 | -2.17K% |
| September 30, 2021 | -7.22K% |
| June 30, 2021 | -13.15K% |
| March 31, 2021 | -8.42K% |
| December 31, 2020 | -25.97K% |
| September 30, 2020 | -4.42K% |
| June 30, 2020 | -6.61K% |
| March 31, 2020 | -2.85K% |
| December 31, 2019 | -3.21K% |
| September 30, 2019 | -1.12K% |
| June 30, 2019 | -1.83K% |
| Date | Value |
|---|---|
| March 31, 2019 | -990.7% |
| December 31, 2018 | -304.1% |
| September 30, 2018 | -169.8K% |
| June 30, 2018 | -126.5K% |
| March 31, 2018 | -147.8K% |
| December 31, 2017 | -12.21K% |
| September 30, 2017 | -7.81K% |
| June 30, 2017 | -6.92K% |
| March 31, 2017 | -6.76K% |
| December 31, 2016 | -1.58K% |
| September 30, 2016 | -1.56K% |
| June 30, 2016 | -1.17K% |
| March 31, 2016 | -1.63K% |
| December 31, 2015 | -606.7% |
| September 30, 2015 | -345.3% |
| June 30, 2015 | -774.0% |
| March 31, 2015 | 68.33% |
| December 31, 2014 | -178.3% |
| September 30, 2014 | -60.92% |
| June 30, 2014 | -54.64% |
| March 31, 2014 | -12.57% |
| December 31, 2013 | 40.55% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-25.97K%
Minimum
Dec 2020
-63.09%
Maximum
Dec 2023
-4.04K%
Average
-1.58K%
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk AS | 38.28% |
| Evaxion Biotech AS | -64.14% |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -48.84% |
| Return on Invested Capital | -89.94% |
| Gross Profit Margin (Quarterly) | 80.63% |
| Operating Margin (Quarterly) | -167.3% |
| Return on Net Operating Assets | -96.45% |